AN2 Therapeutics Statistics
Total Valuation
ANTX has a market cap or net worth of $32.23 million. The enterprise value is -$72.01 million.
Market Cap | 32.23M |
Enterprise Value | -72.01M |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024, after market close.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ANTX has 29.84 million shares outstanding. The number of shares has increased by 48.11% in one year.
Shares Outstanding | 29.84M |
Shares Change (YoY) | +48.11% |
Shares Change (QoQ) | +0.21% |
Owned by Insiders (%) | 5.93% |
Owned by Institutions (%) | 21.64% |
Float | 11.39M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.33 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.61
Current Ratio | 10.61 |
Quick Ratio | 10.35 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -69.48% and return on invested capital (ROIC) is -47.80%.
Return on Equity (ROE) | -69.48% |
Return on Assets (ROA) | -42.89% |
Return on Capital (ROIC) | -47.80% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.58M |
Employee Count | 41 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.63% in the last 52 weeks. The beta is -0.22, so ANTX's price volatility has been lower than the market average.
Beta (5Y) | -0.22 |
52-Week Price Change | -92.63% |
50-Day Moving Average | 1.07 |
200-Day Moving Average | 3.64 |
Relative Strength Index (RSI) | 50.81 |
Average Volume (20 Days) | 175,048 |
Short Selling Information
The latest short interest is 139,119, so 0.47% of the outstanding shares have been sold short.
Short Interest | 139,119 |
Short Previous Month | 188,480 |
Short % of Shares Out | 0.47% |
Short % of Float | 1.22% |
Short Ratio (days to cover) | 0.84 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -71.17M |
Pretax Income | -66.03M |
Net Income | -64.66M |
EBITDA | n/a |
EBIT | -71.17M |
Earnings Per Share (EPS) | -$2.25 |
Balance Sheet
Cash & Cash Equivalents | 104.54M |
Total Debt | n/a |
Net Cash | 104.54M |
Net Cash Per Share | $3.50 |
Equity (Book Value) | 98.35M |
Book Value Per Share | 3.30 |
Working Capital | 97.31M |
Cash Flow
Operating Cash Flow | -60.85M |
Capital Expenditures | n/a |
Free Cash Flow | -60.85M |
FCF Per Share | -$2.04 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ANTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -48.11% |
Shareholder Yield | -48.11% |
Earnings Yield | -198.77% |
FCF Yield | -187.05% |
Analyst Forecast
The average price target for ANTX is $2.50, which is 131.48% higher than the current price. The consensus rating is "Buy".
Price Target | $2.50 |
Price Target Difference | 131.48% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |